Cynapsus Therapeutics (CYNA) Announces Enrollment of Last Patient in CTH-300 Phase 3 for OFF Episodes
Tweet Send to a Friend
Cynapsus Therapeutics Inc. (Nasdaq: CYNA) announced that the last patient has been enrolled in its pivotal Phase 3 efficacy study ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
